We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$618M
AUM Growth
-$43.1M
Cap. Flow
-$63.8M
Cap. Flow %
-10.32%
Top 10 Hldgs %
7.4%
Holding
973
New
156
Increased
203
Reduced
222
Closed
372

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$3.94M
2
MRSH
Marsh
MRSH
+$3.18M
3
DXC icon
DXC Technology
DXC
+$3.13M
4
WAT icon
Waters Corp
WAT
+$3.01M
5
DPZ icon
Domino's
DPZ
+$2.73M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$3.17M
2
ATKR icon
Atkore
ATKR
+$3.17M
3
ANET icon
Arista Networks
ANET
+$3.02M
4
ENPH icon
Enphase Energy
ENPH
+$3M
5
EVH icon
Evolent Health
EVH
+$2.97M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Healthcare 18.83%
3 Financials 14.91%
4 Industrials 13.43%
5 Consumer Discretionary 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HE icon
451
Hawaiian Electric Industries
HE
$2.26B
$358K 0.06%
8,565
+2
+0% +$77
SWAV
452
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$355K 0.06%
1,726
-174
-9% -$44K
CXT icon
453
Crane NXT
CXT
$2.99B
$354K 0.06%
+10,134
New +$353K
AIN icon
454
Albany International
AIN
$2.09B
$352K 0.06%
3,571
-7,973
-69% -$761K
WSO icon
455
Watsco Inc
WSO
$13.2B
$351K 0.06%
+1,408
New +$370K
DSEY
456
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$345K 0.06%
81,019
DBRG icon
457
DigitalBridge
DBRG
$2.92B
$339K 0.05%
30,948
-15,411
-33% -$200K
CCCC icon
458
C4 Therapeutics
CCCC
$389M
$338K 0.05%
57,372
+15,685
+38% +$130K
EBIX
459
DELISTED
Ebix Inc
EBIX
$337K 0.05%
+16,889
New +$327K
TBI
460
Trueblue
TBI
$227M
$337K 0.05%
17,211
-15,609
-48% -$316K
VITL icon
461
Vital Farms
VITL
$586M
$332K 0.05%
22,230
-10,078
-31% -$139K
HUBB icon
462
Hubbell
HUBB
$24.4B
$331K 0.05%
+1,410
New +$338K
LRN icon
463
Stride
LRN
$4.16B
$331K 0.05%
+10,572
New +$388K
BMI icon
464
Badger Meter
BMI
$3.87B
$330K 0.05%
3,023
+285
+10% +$31K
INCY icon
465
Incyte
INCY
$25.4B
$329K 0.05%
+4,100
New +$314K
MX icon
466
Magnachip Semiconductor
MX
$110M
$328K 0.05%
+34,926
New +$338K
SPWR
467
DELISTED
SunPower Corporation Common Stock
SPWR
$328K 0.05%
18,178
-37,202
-67% -$762K
KFRC icon
468
Kforce
KFRC
$1.05B
$325K 0.05%
+5,924
New +$342K
FWRG icon
469
First Watch Restaurant Group
FWRG
$814M
$325K 0.05%
+23,985
New +$365K
ACN icon
470
Accenture
ACN
$106B
$323K 0.05%
1,209
-1,091
-47% -$302K
ALKT icon
471
Alkami Technology
ALKT
$1.96B
$321K 0.05%
+21,999
New +$307K
CTKB icon
472
Cytek Biosciences
CTKB
$566M
$320K 0.05%
31,381
-55
-0.2% -$739
TEX icon
473
Terex
TEX
$7.37B
$318K 0.05%
+7,453
New +$300K
KALV
474
DELISTED
KalVista Pharmaceuticals
KALV
$318K 0.05%
+47,044
New +$252K
AVIR icon
475
Atea Pharmaceuticals
AVIR
$370M
$317K 0.05%
65,985
-2,769
-4% -$14K

Similar funds

PDT Partners's Q4 2022 Portfolio in Review

As of Q4 2022, PDT Partners held 973 positions worth $618M, down 6.5% from $661M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

PDT Partners withdrew a net $63.8M in Q4 2022, closing 372 positions and reducing 222 holdings. Its most notable exit was Honeywell, an estimated $3.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Guardant Health worth $2.34M.

  • PDT Partners's largest Q4 2022 buy was Guardant Health: 86,159 shares worth $2.34M.
  • PDT Partners added most to Waters Corp in Q4 2022, an estimated $3.01M increase.
  • PDT Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $3M.
  • PDT Partners fully exited Honeywell in Q4 2022, selling an estimated $3.17M.
  • PDT Partners's ten largest holdings make up 7.4% of its $618M portfolio in Q4 2022.
  • PDT Partners opened 156 new positions and closed 372 in Q4 2022.
  • PDT Partners's portfolio value fell 6.5% quarter-over-quarter to $618M.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.